Announce Date | 04/30/2025 |
EPS Normalized Actual | $2.38 (Beat by $0.04) |
EPS GAAP Actual | $2.38 (Beat by $0.04) |
Revenue Actual | $3.839B |
Revenue Surprise | Beat by $3839M |
Announce Date | 06/30/2025 (Pre-Market) |
EPS Normalized Estimate | $2.72624 |
EPS GAAP Estimate | $2.72624 |
Revenue Estimate | $4.257403903B |
Fiscal Period Ending | EPS Estimate | Forward PE | Low | High | # of Analysts |
---|---|---|---|---|---|
Dec 2028 | 13.46 | 18.02 | 13.13738 | 13.7493 | 5 |
Dec 2027 | 12.97 | 18.7 | 12.67995 | 13.22124 | 5 |
Period | EPS | Beat / Miss | Revenue | YoY | Beat / Miss |
---|---|---|---|---|---|
FQ1 2025 (Mar 2025) | 2.39 | 2.39 | 3.839B | -3.49% | 3839M |
FQ4 2024 (Dec 2024) | 2.53 | 2.53 | 3.932B | -1.3% | 3932M |
FQ3 2024 (Sep 2024) | 3.92 | 3.92 | 3.966B | -1.64% | 3966M |
FQ2 2024 (Jun 2024) | 2.55 | 2.55 | 4.027B | -1.17% | 4027M |
FQ1 2024 (Mar 2024) | 2.74 | 2.74 | 3.973B | -1.16% | 3973M |
FQ4 2023 (Dec 2023) | 0 | 0 | 3.983B | 0.3% | 3983M |
FQ3 2023 (Sep 2023) | 2.55 | 2.55 | 4.031B | 0.5% | 4031M |
FQ2 2023 (Jun 2023) | 2.49 | 2.49 | 4.074B | 1.55% | 4074M |
FQ4 Announce Date
06/30/2025 (Pre-Market)
Consensus EPS Estimates
2.72624
Consensus Revenue Estimates
4.257403903B
Fiscal Period Ending | EPS Estimate | YoY Growth(%) | Low | High | # of Analysts |
---|---|---|---|---|---|
FQ4 2027 (Dec 2027) | 3.03728 | -- | 2.95992 | 3.10664 | 8 |
FQ3 2027 (Sep 2027) | 3.11208 | -- | 3.03281 | 3.18315 | 8 |
FQ2 2027 (Jun 2027) | 2.95919 | -- | 2.88382 | 3.02677 | 8 |
FQ1 2027 (Mar 2027) | 2.73263 | -- | 2.66303 | 2.79504 | 8 |
FQ4 2026 (Oct 2026) | 2.84068 | -- | 2.75048 | 2.89534 | 7 |
FQ3 2026 (Jul 2026) | 2.76344 | -- | 2.67569 | 2.81661 | 4 |
FQ2 2026 (Jun 2026) | 2.81524 | -- | 2.75482 | 2.87152 | 4 |
FQ1 2026 (Mar 2026) | 2.64405 | 9.61 | 2.5873 | 2.69691 | 4 |
FQ4 2025 (Oct 2025) | 2.78413 | 9.13 | 2.69572 | 2.8377 | 7 |
FQ3 2025 (Jul 2025) | 2.69238 | -45.6 | 2.60689 | 2.74419 | 5 |
FQ2 2025 (Jun 2025) | 2.72624 | 6.46 | 2.66438 | 2.7814 | 5 |
Fiscal Period Ending | Revenue Estimate | YoY Growth(%) | Low | High | # of Analysts |
---|---|---|---|---|---|
FQ4 2027 (Dec 2027) | 4.14B | -- | 4.06B | 4.21B | 5 |
FQ3 2027 (Sep 2027) | 4.16B | -- | 4.08B | 4.24B | 4 |
FQ2 2027 (Jun 2027) | 4.2B | -- | 4.12B | 4.27B | 5 |
FQ1 2027 (Mar 2027) | 4.02B | -- | 3.95B | 4.09B | 4 |
FQ4 2026 (Oct 2026) | 4.23B | -- | 4.13B | 4.29B | 5 |
FQ3 2026 (Jul 2026) | 4.29B | -- | 4.18B | 4.35B | 5 |
FQ2 2026 (Jun 2026) | 4.36B | -- | 4.29B | 4.43B | 5 |
FQ1 2026 (Mar 2026) | 4.25B | 9.57 | 4.18B | 4.31B | 5 |
FQ4 2025 (Oct 2025) | 4.24B | 7.25 | 4.14B | 4.3B | 4 |
FQ3 2025 (Jul 2025) | 4.22B | 5.98 | 4.12B | 4.28B | 4 |
FQ2 2025 (Jun 2025) | 4.26B | 5.41 | 4.18B | 4.32B | 4 |
EPS # of Up Revisions
4
EPS # of Down Revisions
4
Revenue # of Up Revisions
6
Revenue # of Down Revisions
3
Fiscal Period Ending | EPS Estimate | YoY Growth | Low | High | # of Analysts |
---|---|---|---|---|---|
FQ4 2021 (Dec 2021) | 0.41 | -12.52% | 0.39 | 0.48 | 20 |
FQ1 2022 (Mar 2022) | 0.59 | 6.89% | 0.55 | 0.62 | 15 |
FQ2 2022 (Jun 2022) | 0.70 | 2.62% | 0.61 | 0.74 | 15 |
FQ3 2022 (Sep 2022) | 0.68 | 4.62% | 0.65 | 0.70 | 15 |
Fiscal Period Ending | EPS Estimate | YoY Growth | Low | High | # of Analysts |
---|---|---|---|---|---|
FQ4 2021 (Dec 2021) | 0.41 | -12.52% | 0.39 | 0.48 | 20 |
FQ1 2022 (Mar 2022) | 0.59 | 6.89% | 0.55 | 0.62 | 15 |
FQ2 2022 (Jun 2022) | 0.70 | 2.62% | 0.61 | 0.74 | 15 |
FQ3 2022 (Sep 2022) | 0.68 | 4.62% | 0.65 | 0.70 | 15 |
EPS # of Beats
7
EPS # of Misses
0
EPS # of in-lines
1
Revenue # of Beats
8
Revenue # of Misses
0
Revenue # of in-lines
0
Earnings Date | EPS Estimate | EPS Actual | Surprise | Surprise % |
---|---|---|---|---|
FQ1 2025 (Mar 2025) | 2.39 | 2.39 | 100% | |
FQ4 2024 (Dec 2024) | 2.53 | 2.53 | 100% | |
FQ3 2024 (Sep 2024) | 3.92 | 3.92 | 100% | |
FQ2 2024 (Jun 2024) | 2.55 | 2.55 | 100% | |
FQ1 2024 (Mar 2024) | 2.74 | 2.74 | 100% | |
FQ4 2023 (Dec 2023) | 0 | 0 | NAN% | |
FQ3 2023 (Sep 2023) | 2.55 | 2.55 | 100% | |
FQ2 2023 (Jun 2023) | 2.49 | 2.49 | 100% |
Earnings Date | Revenue Estimate | Revenue Actual | Surprise | Surprise % |
---|---|---|---|---|
FQ1 2025 (Mar 2025) | $0B | $3.84B | $3839M | 100% |
FQ4 2024 (Dec 2024) | $0B | $3.93B | $3932M | 100% |
FQ3 2024 (Sep 2024) | $0B | $3.97B | $3966M | 100% |
FQ2 2024 (Jun 2024) | $0B | $4.03B | $4027M | 100% |
FQ1 2024 (Mar 2024) | $0B | $3.97B | $3973M | 100% |
FQ4 2023 (Dec 2023) | $0B | $3.98B | $3983M | 100% |
FQ3 2023 (Sep 2023) | $0B | $4.03B | $4031M | 100% |
FQ2 2023 (Jun 2023) | $0B | $4.07B | $4074M | 100% |